Aimei Health Technology Co., Ltd.
corporate_fare Company Profile
Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 16 items for AFJK at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for AFJK spans 8-K, PRE 14A, 10-Q, 10-K.
Recent high-impact activity:
- Aimei Shareholders Approve 12-Month Extension; 841,629 Shares Redeemed, Trust Falls to $2.45M
- Aimei Signs Non-Binding LOI to Merge With Hera Health Solutions
- Aimei Health Seeks Shareholder Vote to Extend SPAC Deadline to December 2027
- Aimei Health Receives Nasdaq Delisting Notices for MVLS and MVPHS Deficiencies
- Aimei Health Q2 Loss Widens, Cash Dwindles to $1,466 as SPAC Deadline Looms
Financial Snapshot
Short Interest & Short Volume
1.46 days to coverFINRA reported short interest of 1,641 shares in AFJK as of the October 30, 2026 settlement, a 26.8% decrease from the prior period — about 1.5 days to cover at its recent average daily volume. On November 20, 2026, 31.4% of AFJK volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.